Natera, Inc. (NTRA)
Sale of 200 shares at $406.50 per share.
Reporting Person Sheena Jonathan · Transaction Code S
Traded Oct 21, 2026 · Disclosed Oct 23, 2026
Source: SEC Form 4 · 0001646649-26-000035 · filed 2026-10-23 · View filing →
Company
NTRA · CIK 0001604821
Sale of 200 shares at $406.50 per share.
Reporting Person Sheena Jonathan · Transaction Code S
Traded Oct 21, 2026 · Disclosed Oct 23, 2026
Source: SEC Form 4 · 0001646649-26-000035 · filed 2026-10-23 · View filing →
Sale of 962 shares at $408.2584 per share.
Reporting Person Sheena Jonathan · Transaction Code S
Traded Oct 21, 2026 · Disclosed Oct 23, 2026
Source: SEC Form 4 · 0001646649-26-000035 · filed 2026-10-23 · View filing →
Sale of 627 shares at $409.8932 per share.
Reporting Person Sheena Jonathan · Transaction Code S
Traded Oct 21, 2026 · Disclosed Oct 23, 2026
Source: SEC Form 4 · 0001646649-26-000035 · filed 2026-10-23 · View filing →
Sale of 605 shares at $411.3175 per share.
Reporting Person Sheena Jonathan · Transaction Code S
Traded Oct 21, 2026 · Disclosed Oct 23, 2026
Source: SEC Form 4 · 0001646649-26-000035 · filed 2026-10-23 · View filing →
Sale of 211 shares at $412.1991 per share.
Reporting Person Sheena Jonathan · Transaction Code S
Traded Oct 21, 2026 · Disclosed Oct 23, 2026
Source: SEC Form 4 · 0001646649-26-000035 · filed 2026-10-23 · View filing →
Sale of 125 shares at $413.0476 per share.
Reporting Person Sheena Jonathan · Transaction Code S
Traded Oct 21, 2026 · Disclosed Oct 23, 2026
Source: SEC Form 4 · 0001646649-26-000035 · filed 2026-10-23 · View filing →
Sale of 255 shares at $415.6659 per share.
Reporting Person Sheena Jonathan · Transaction Code S
Traded Oct 21, 2026 · Disclosed Oct 23, 2026
Source: SEC Form 4 · 0001646649-26-000035 · filed 2026-10-23 · View filing →
Sale of 165 shares at $416.6736 per share.
Reporting Person Sheena Jonathan · Transaction Code S
Traded Oct 21, 2026 · Disclosed Oct 23, 2026
Source: SEC Form 4 · 0001646649-26-000035 · filed 2026-10-23 · View filing →
Sale of 215 shares at $399.3403 per share.
Reporting Person Sheena Jonathan · Transaction Code S
Traded Oct 16, 2026 · Disclosed Oct 20, 2026
Source: SEC Form 4 · 0001646649-26-000034 · filed 2026-10-20 · View filing →
Sale of 90 shares at $403.6972 per share.
Reporting Person Sheena Jonathan · Transaction Code S
Traded Oct 16, 2026 · Disclosed Oct 20, 2026
Source: SEC Form 4 · 0001646649-26-000034 · filed 2026-10-20 · View filing →
Sale of 80 shares at $406.0563 per share.
Reporting Person Sheena Jonathan · Transaction Code S
Traded Oct 16, 2026 · Disclosed Oct 20, 2026
Source: SEC Form 4 · 0001646649-26-000034 · filed 2026-10-20 · View filing →
Sale of 98 shares at $409.3438 per share.
Reporting Person Sheena Jonathan · Transaction Code S
Traded Oct 16, 2026 · Disclosed Oct 20, 2026
Source: SEC Form 4 · 0001646649-26-000034 · filed 2026-10-20 · View filing →
Sale of 280 shares at $401.2871 per share.
Reporting Person Sheena Jonathan · Transaction Code S
Traded Oct 16, 2026 · Disclosed Oct 20, 2026
Source: SEC Form 4 · 0001646649-26-000034 · filed 2026-10-20 · View filing →
Sale of 90 shares at $404.2528 per share.
Reporting Person Sheena Jonathan · Transaction Code S
Traded Oct 16, 2026 · Disclosed Oct 20, 2026
Source: SEC Form 4 · 0001646649-26-000034 · filed 2026-10-20 · View filing →
Sale of 50 shares at $405.1500 per share.
Reporting Person Sheena Jonathan · Transaction Code S
Traded Oct 16, 2026 · Disclosed Oct 20, 2026
Source: SEC Form 4 · 0001646649-26-000034 · filed 2026-10-20 · View filing →
Sale of 35 shares at $406.6250 per share.
Reporting Person Sheena Jonathan · Transaction Code S
Traded Oct 16, 2026 · Disclosed Oct 20, 2026
Source: SEC Form 4 · 0001646649-26-000034 · filed 2026-10-20 · View filing →
Sale of 80 shares at $409.3575 per share.
Reporting Person Sheena Jonathan · Transaction Code S
Traded Oct 16, 2026 · Disclosed Oct 20, 2026
Source: SEC Form 4 · 0001646649-26-000034 · filed 2026-10-20 · View filing →
Sale of 142 shares at $398.9536 per share.
Reporting Person Sheena Jonathan · Transaction Code S
Traded Oct 16, 2026 · Disclosed Oct 20, 2026
Source: SEC Form 4 · 0001646649-26-000034 · filed 2026-10-20 · View filing →
Sale of 280 shares at $400.6765 per share.
Reporting Person Sheena Jonathan · Transaction Code S
Traded Oct 16, 2026 · Disclosed Oct 20, 2026
Source: SEC Form 4 · 0001646649-26-000034 · filed 2026-10-20 · View filing →
Sale of 60 shares at $401.6200 per share.
Reporting Person Sheena Jonathan · Transaction Code S
Traded Oct 16, 2026 · Disclosed Oct 20, 2026
Source: SEC Form 4 · 0001646649-26-000034 · filed 2026-10-20 · View filing →
Acquisition (code M) of 50,000 shares at $10.41 per share.
Reporting Person Rabinowitz Matthew · Officer Title EXECUTIVE CHAIRMAN · Transaction Code M
Traded Oct 15, 2026 · Disclosed Oct 16, 2026
Source: SEC Form 4 · 0001646382-26-000023 · filed 2026-10-16 · View filing →
Sale of 600 shares at $398.0898 per share.
Reporting Person Rabinowitz Matthew · Officer Title EXECUTIVE CHAIRMAN · Transaction Code S
Traded Oct 15, 2026 · Disclosed Oct 16, 2026
Source: SEC Form 4 · 0001646382-26-000023 · filed 2026-10-16 · View filing →
Sale of 793 shares at $399.3128 per share.
Reporting Person Rabinowitz Matthew · Officer Title EXECUTIVE CHAIRMAN · Transaction Code S
Traded Oct 15, 2026 · Disclosed Oct 16, 2026
Source: SEC Form 4 · 0001646382-26-000023 · filed 2026-10-16 · View filing →
Sale of 2,671 shares at $400.3091 per share.
Reporting Person Rabinowitz Matthew · Officer Title EXECUTIVE CHAIRMAN · Transaction Code S
Traded Oct 15, 2026 · Disclosed Oct 16, 2026
Source: SEC Form 4 · 0001646382-26-000023 · filed 2026-10-16 · View filing →
Sale of 5,974 shares at $401.4219 per share.
Reporting Person Rabinowitz Matthew · Officer Title EXECUTIVE CHAIRMAN · Transaction Code S
Traded Oct 15, 2026 · Disclosed Oct 16, 2026
Source: SEC Form 4 · 0001646382-26-000023 · filed 2026-10-16 · View filing →
Sale of 6,309 shares at $402.2323 per share.
Reporting Person Rabinowitz Matthew · Officer Title EXECUTIVE CHAIRMAN · Transaction Code S
Traded Oct 15, 2026 · Disclosed Oct 16, 2026
Source: SEC Form 4 · 0001646382-26-000023 · filed 2026-10-16 · View filing →
Sale of 3,858 shares at $403.2655 per share.
Reporting Person Rabinowitz Matthew · Officer Title EXECUTIVE CHAIRMAN · Transaction Code S
Traded Oct 15, 2026 · Disclosed Oct 16, 2026
Source: SEC Form 4 · 0001646382-26-000023 · filed 2026-10-16 · View filing →
Sale of 10,321 shares at $404.6416 per share.
Reporting Person Rabinowitz Matthew · Officer Title EXECUTIVE CHAIRMAN · Transaction Code S
Traded Oct 15, 2026 · Disclosed Oct 16, 2026
Source: SEC Form 4 · 0001646382-26-000023 · filed 2026-10-16 · View filing →
Sale of 6,274 shares at $405.1795 per share.
Reporting Person Rabinowitz Matthew · Officer Title EXECUTIVE CHAIRMAN · Transaction Code S
Traded Oct 15, 2026 · Disclosed Oct 16, 2026
Source: SEC Form 4 · 0001646382-26-000023 · filed 2026-10-16 · View filing →
Sale of 1,400 shares at $406.6299 per share.
Reporting Person Rabinowitz Matthew · Officer Title EXECUTIVE CHAIRMAN · Transaction Code S
Traded Oct 15, 2026 · Disclosed Oct 16, 2026
Source: SEC Form 4 · 0001646382-26-000023 · filed 2026-10-16 · View filing →
Sale of 3,800 shares at $407.2662 per share.
Reporting Person Rabinowitz Matthew · Officer Title EXECUTIVE CHAIRMAN · Transaction Code S
Traded Oct 15, 2026 · Disclosed Oct 16, 2026
Source: SEC Form 4 · 0001646382-26-000023 · filed 2026-10-16 · View filing →
Sale of 286 shares at $388.3187 per share.
Reporting Person Rabinowitz Matthew · Officer Title EXECUTIVE CHAIRMAN · Transaction Code S
Traded Oct 15, 2026 · Disclosed Oct 16, 2026
Source: SEC Form 4 · 0001646382-26-000023 · filed 2026-10-16 · View filing →
Sale of 2,000 shares at $408.2356 per share.
Reporting Person Rabinowitz Matthew · Officer Title EXECUTIVE CHAIRMAN · Transaction Code S
Traded Oct 15, 2026 · Disclosed Oct 16, 2026
Source: SEC Form 4 · 0001646382-26-000023 · filed 2026-10-16 · View filing →
Sale of 714 shares at $389.8392 per share.
Reporting Person Rabinowitz Matthew · Officer Title EXECUTIVE CHAIRMAN · Transaction Code S
Traded Oct 15, 2026 · Disclosed Oct 16, 2026
Source: SEC Form 4 · 0001646382-26-000023 · filed 2026-10-16 · View filing →
Sale of 600 shares at $390.2052 per share.
Reporting Person Rabinowitz Matthew · Officer Title EXECUTIVE CHAIRMAN · Transaction Code S
Traded Oct 15, 2026 · Disclosed Oct 16, 2026
Source: SEC Form 4 · 0001646382-26-000023 · filed 2026-10-16 · View filing →
Sale of 300 shares at $391.5767 per share.
Reporting Person Rabinowitz Matthew · Officer Title EXECUTIVE CHAIRMAN · Transaction Code S
Traded Oct 15, 2026 · Disclosed Oct 16, 2026
Source: SEC Form 4 · 0001646382-26-000023 · filed 2026-10-16 · View filing →
Sale of 800 shares at $393.4713 per share.
Reporting Person Rabinowitz Matthew · Officer Title EXECUTIVE CHAIRMAN · Transaction Code S
Traded Oct 15, 2026 · Disclosed Oct 16, 2026
Source: SEC Form 4 · 0001646382-26-000023 · filed 2026-10-16 · View filing →
Sale of 300 shares at $394.3950 per share.
Reporting Person Rabinowitz Matthew · Officer Title EXECUTIVE CHAIRMAN · Transaction Code S
Traded Oct 15, 2026 · Disclosed Oct 16, 2026
Source: SEC Form 4 · 0001646382-26-000023 · filed 2026-10-16 · View filing →
Sale of 1,900 shares at $396.3048 per share.
Reporting Person Rabinowitz Matthew · Officer Title EXECUTIVE CHAIRMAN · Transaction Code S
Traded Oct 15, 2026 · Disclosed Oct 16, 2026
Source: SEC Form 4 · 0001646382-26-000023 · filed 2026-10-16 · View filing →
Sale of 1,100 shares at $397.1592 per share.
Reporting Person Rabinowitz Matthew · Officer Title EXECUTIVE CHAIRMAN · Transaction Code S
Traded Oct 15, 2026 · Disclosed Oct 16, 2026
Source: SEC Form 4 · 0001646382-26-000023 · filed 2026-10-16 · View filing →
Sale of 1,273 shares at $413.31 per share.
Reporting Person Chapman Steven Leonard · Officer Title CEO AND PRESIDENT · Transaction Code S
Traded Oct 1, 2026 · Disclosed Oct 2, 2026
Source: SEC Form 4 · 0001711968-26-000023 · filed 2026-10-02 · View filing →
Sale of 200 shares at $411.62 per share.
Reporting Person Moshkevich Solomon · Officer Title PRESIDENT, CLINICALDIAGNOSTICS · Transaction Code S
Traded Oct 1, 2026 · Disclosed Oct 2, 2026
Source: SEC Form 4 · 0002010019-26-000030 · filed 2026-10-02 · View filing →
Sale of 954 shares at $413.1066 per share.
Reporting Person Moshkevich Solomon · Officer Title PRESIDENT, CLINICALDIAGNOSTICS · Transaction Code S
Traded Oct 1, 2026 · Disclosed Oct 2, 2026
Source: SEC Form 4 · 0002010019-26-000030 · filed 2026-10-02 · View filing →
Sale of 1,846 shares at $415.0691 per share.
Reporting Person Moshkevich Solomon · Officer Title PRESIDENT, CLINICALDIAGNOSTICS · Transaction Code S
Traded Oct 1, 2026 · Disclosed Oct 2, 2026
Source: SEC Form 4 · 0002010019-26-000030 · filed 2026-10-02 · View filing →
Sale of 400 shares at $385.1025 per share.
Reporting Person Sheena Jonathan · Transaction Code S
Traded Sep 23, 2026 · Disclosed Sep 25, 2026
Source: SEC Form 4 · 0001646649-26-000033 · filed 2026-09-25 · View filing →
Sale of 1,341 shares at $388.7637 per share.
Reporting Person Sheena Jonathan · Transaction Code S
Traded Sep 23, 2026 · Disclosed Sep 25, 2026
Source: SEC Form 4 · 0001646649-26-000033 · filed 2026-09-25 · View filing →
Sale of 1,935 shares at $389.7108 per share.
Reporting Person Sheena Jonathan · Transaction Code S
Traded Sep 23, 2026 · Disclosed Sep 25, 2026
Source: SEC Form 4 · 0001646649-26-000033 · filed 2026-09-25 · View filing →
Sale of 220 shares at $390.5250 per share.
Reporting Person Sheena Jonathan · Transaction Code S
Traded Sep 23, 2026 · Disclosed Sep 25, 2026
Source: SEC Form 4 · 0001646649-26-000033 · filed 2026-09-25 · View filing →
Sale of 2,175 shares at $386.7144 per share.
Reporting Person Sheena Jonathan · Transaction Code S
Traded Sep 23, 2026 · Disclosed Sep 25, 2026
Source: SEC Form 4 · 0001646649-26-000033 · filed 2026-09-25 · View filing →
Sale of 2,734 shares at $387.6545 per share.
Reporting Person Sheena Jonathan · Transaction Code S
Traded Sep 23, 2026 · Disclosed Sep 25, 2026
Source: SEC Form 4 · 0001646649-26-000033 · filed 2026-09-25 · View filing →
Sale of 1,293 shares at $388.7071 per share.
Reporting Person Sheena Jonathan · Transaction Code S
Traded Sep 23, 2026 · Disclosed Sep 25, 2026
Source: SEC Form 4 · 0001646649-26-000033 · filed 2026-09-25 · View filing →
Sale of 2,320 shares at $389.6850 per share.
Reporting Person Sheena Jonathan · Transaction Code S
Traded Sep 23, 2026 · Disclosed Sep 25, 2026
Source: SEC Form 4 · 0001646649-26-000033 · filed 2026-09-25 · View filing →
Sale of 110 shares at $390.42 per share.
Reporting Person Sheena Jonathan · Transaction Code S
Traded Sep 23, 2026 · Disclosed Sep 25, 2026
Source: SEC Form 4 · 0001646649-26-000033 · filed 2026-09-25 · View filing →
Sale of 390 shares at $385.2906 per share.
Reporting Person Sheena Jonathan · Transaction Code S
Traded Sep 23, 2026 · Disclosed Sep 25, 2026
Source: SEC Form 4 · 0001646649-26-000033 · filed 2026-09-25 · View filing →
Sale of 2,300 shares at $386.6396 per share.
Reporting Person Sheena Jonathan · Transaction Code S
Traded Sep 23, 2026 · Disclosed Sep 25, 2026
Source: SEC Form 4 · 0001646649-26-000033 · filed 2026-09-25 · View filing →
Sale of 2,846 shares at $387.7351 per share.
Reporting Person Sheena Jonathan · Transaction Code S
Traded Sep 23, 2026 · Disclosed Sep 25, 2026
Source: SEC Form 4 · 0001646649-26-000033 · filed 2026-09-25 · View filing →
Sale of 200 shares at $348.0250 per share.
Reporting Person Sheena Jonathan · Transaction Code S
Traded Sep 16, 2026 · Disclosed Sep 17, 2026
Source: SEC Form 4 · 0001646649-26-000032 · filed 2026-09-17 · View filing →
Sale of 100 shares at $349.0450 per share.
Reporting Person Sheena Jonathan · Transaction Code S
Traded Sep 16, 2026 · Disclosed Sep 17, 2026
Source: SEC Form 4 · 0001646649-26-000032 · filed 2026-09-17 · View filing →
Sale of 1,400 shares at $353.83 per share.
Reporting Person Sheena Jonathan · Transaction Code S
Traded Sep 16, 2026 · Disclosed Sep 17, 2026
Source: SEC Form 4 · 0001646649-26-000032 · filed 2026-09-17 · View filing →
Sale of 450 shares at $354.9133 per share.
Reporting Person Sheena Jonathan · Transaction Code S
Traded Sep 16, 2026 · Disclosed Sep 17, 2026
Source: SEC Form 4 · 0001646649-26-000032 · filed 2026-09-17 · View filing →
Sale of 800 shares at $355.9475 per share.
Reporting Person Sheena Jonathan · Transaction Code S
Traded Sep 16, 2026 · Disclosed Sep 17, 2026
Source: SEC Form 4 · 0001646649-26-000032 · filed 2026-09-17 · View filing →
Sale of 200 shares at $356.8664 per share.
Reporting Person Sheena Jonathan · Transaction Code S
Traded Sep 16, 2026 · Disclosed Sep 17, 2026
Source: SEC Form 4 · 0001646649-26-000032 · filed 2026-09-17 · View filing →
Sale of 6,000 shares at $350.0718 per share.
Reporting Person Sheena Jonathan · Transaction Code S
Traded Sep 15, 2026 · Disclosed Sep 17, 2026
Source: SEC Form 4 · 0001646649-26-000032 · filed 2026-09-17 · View filing →
Sale of 1,481 shares at $339.2351 per share.
Reporting Person Rabinowitz Matthew · Officer Title EXECUTIVE CHAIRMAN · Transaction Code S
Traded Sep 15, 2026 · Disclosed Sep 16, 2026
Source: SEC Form 4 · 0001646382-26-000021 · filed 2026-09-16 · View filing →
Sale of 2,549 shares at $340.2485 per share.
Reporting Person Rabinowitz Matthew · Officer Title EXECUTIVE CHAIRMAN · Transaction Code S
Traded Sep 15, 2026 · Disclosed Sep 16, 2026
Source: SEC Form 4 · 0001646382-26-000021 · filed 2026-09-16 · View filing →
Sale of 1,813 shares at $341.4067 per share.
Reporting Person Rabinowitz Matthew · Officer Title EXECUTIVE CHAIRMAN · Transaction Code S
Traded Sep 15, 2026 · Disclosed Sep 16, 2026
Source: SEC Form 4 · 0001646382-26-000021 · filed 2026-09-16 · View filing →
Sale of 1,956 shares at $342.1804 per share.
Reporting Person Rabinowitz Matthew · Officer Title EXECUTIVE CHAIRMAN · Transaction Code S
Traded Sep 15, 2026 · Disclosed Sep 16, 2026
Source: SEC Form 4 · 0001646382-26-000021 · filed 2026-09-16 · View filing →
Sale of 2,240 shares at $343.5638 per share.
Reporting Person Rabinowitz Matthew · Officer Title EXECUTIVE CHAIRMAN · Transaction Code S
Traded Sep 15, 2026 · Disclosed Sep 16, 2026
Source: SEC Form 4 · 0001646382-26-000021 · filed 2026-09-16 · View filing →
Sale of 5,839 shares at $344.4859 per share.
Reporting Person Rabinowitz Matthew · Officer Title EXECUTIVE CHAIRMAN · Transaction Code S
Traded Sep 15, 2026 · Disclosed Sep 16, 2026
Source: SEC Form 4 · 0001646382-26-000021 · filed 2026-09-16 · View filing →
Sale of 2,700 shares at $345.3798 per share.
Reporting Person Rabinowitz Matthew · Officer Title EXECUTIVE CHAIRMAN · Transaction Code S
Traded Sep 15, 2026 · Disclosed Sep 16, 2026
Source: SEC Form 4 · 0001646382-26-000021 · filed 2026-09-16 · View filing →
Sale of 1,122 shares at $346.6751 per share.
Reporting Person Rabinowitz Matthew · Officer Title EXECUTIVE CHAIRMAN · Transaction Code S
Traded Sep 15, 2026 · Disclosed Sep 16, 2026
Source: SEC Form 4 · 0001646382-26-000021 · filed 2026-09-16 · View filing →
Sale of 2,700 shares at $347.8127 per share.
Reporting Person Rabinowitz Matthew · Officer Title EXECUTIVE CHAIRMAN · Transaction Code S
Traded Sep 15, 2026 · Disclosed Sep 16, 2026
Source: SEC Form 4 · 0001646382-26-000021 · filed 2026-09-16 · View filing →
Sale of 8,094 shares at $348.6465 per share.
Reporting Person Rabinowitz Matthew · Officer Title EXECUTIVE CHAIRMAN · Transaction Code S
Traded Sep 15, 2026 · Disclosed Sep 16, 2026
Source: SEC Form 4 · 0001646382-26-000021 · filed 2026-09-16 · View filing →
Sale of 4,206 shares at $349.5097 per share.
Reporting Person Rabinowitz Matthew · Officer Title EXECUTIVE CHAIRMAN · Transaction Code S
Traded Sep 15, 2026 · Disclosed Sep 16, 2026
Source: SEC Form 4 · 0001646382-26-000021 · filed 2026-09-16 · View filing →
Sale of 14,500 shares at $350.8069 per share.
Reporting Person Rabinowitz Matthew · Officer Title EXECUTIVE CHAIRMAN · Transaction Code S
Traded Sep 15, 2026 · Disclosed Sep 16, 2026
Source: SEC Form 4 · 0001646382-26-000021 · filed 2026-09-16 · View filing →
Sale of 800 shares at $351.2450 per share.
Reporting Person Rabinowitz Matthew · Officer Title EXECUTIVE CHAIRMAN · Transaction Code S
Traded Sep 15, 2026 · Disclosed Sep 16, 2026
Source: SEC Form 4 · 0001646382-26-000021 · filed 2026-09-16 · View filing →
Sale of 2,000 shares at $350.0072 per share.
Reporting Person Rabinowitz Matthew · Officer Title EXECUTIVE CHAIRMAN · Transaction Code S
Traded Sep 15, 2026 · Disclosed Sep 16, 2026
Source: SEC Form 4 · 0001646382-26-000021 · filed 2026-09-16 · View filing →
Sale of 1,537 shares at $328.0942 per share.
Reporting Person Rabinowitz Matthew · Officer Title EXECUTIVE CHAIRMAN · Transaction Code S
Traded Sep 14, 2026 · Disclosed Sep 16, 2026
Source: SEC Form 4 · 0001646382-26-000021 · filed 2026-09-16 · View filing →
Sale of 2,207 shares at $337.1690 per share.
Reporting Person Rabinowitz Matthew · Officer Title EXECUTIVE CHAIRMAN · Transaction Code S
Traded Sep 14, 2026 · Disclosed Sep 16, 2026
Source: SEC Form 4 · 0001646382-26-000021 · filed 2026-09-16 · View filing →
Sale of 1,400 shares at $338.2960 per share.
Reporting Person Rabinowitz Matthew · Officer Title EXECUTIVE CHAIRMAN · Transaction Code S
Traded Sep 14, 2026 · Disclosed Sep 16, 2026
Source: SEC Form 4 · 0001646382-26-000021 · filed 2026-09-16 · View filing →
Sale of 2,100 shares at $339.3681 per share.
Reporting Person Rabinowitz Matthew · Officer Title EXECUTIVE CHAIRMAN · Transaction Code S
Traded Sep 14, 2026 · Disclosed Sep 16, 2026
Source: SEC Form 4 · 0001646382-26-000021 · filed 2026-09-16 · View filing →
Sale of 2,000 shares at $340.3130 per share.
Reporting Person Rabinowitz Matthew · Officer Title EXECUTIVE CHAIRMAN · Transaction Code S
Traded Sep 14, 2026 · Disclosed Sep 16, 2026
Source: SEC Form 4 · 0001646382-26-000021 · filed 2026-09-16 · View filing →
Sale of 2,700 shares at $341.3467 per share.
Reporting Person Rabinowitz Matthew · Officer Title EXECUTIVE CHAIRMAN · Transaction Code S
Traded Sep 14, 2026 · Disclosed Sep 16, 2026
Source: SEC Form 4 · 0001646382-26-000021 · filed 2026-09-16 · View filing →
Sale of 4,064 shares at $342.5067 per share.
Reporting Person Rabinowitz Matthew · Officer Title EXECUTIVE CHAIRMAN · Transaction Code S
Traded Sep 14, 2026 · Disclosed Sep 16, 2026
Source: SEC Form 4 · 0001646382-26-000021 · filed 2026-09-16 · View filing →
Sale of 6,015 shares at $329.1171 per share.
Reporting Person Rabinowitz Matthew · Officer Title EXECUTIVE CHAIRMAN · Transaction Code S
Traded Sep 14, 2026 · Disclosed Sep 16, 2026
Source: SEC Form 4 · 0001646382-26-000021 · filed 2026-09-16 · View filing →
Sale of 6,206 shares at $330.0514 per share.
Reporting Person Rabinowitz Matthew · Officer Title EXECUTIVE CHAIRMAN · Transaction Code S
Traded Sep 14, 2026 · Disclosed Sep 16, 2026
Source: SEC Form 4 · 0001646382-26-000021 · filed 2026-09-16 · View filing →
Sale of 3,494 shares at $330.9752 per share.
Reporting Person Rabinowitz Matthew · Officer Title EXECUTIVE CHAIRMAN · Transaction Code S
Traded Sep 14, 2026 · Disclosed Sep 16, 2026
Source: SEC Form 4 · 0001646382-26-000021 · filed 2026-09-16 · View filing →
Sale of 1,000 shares at $332.0169 per share.
Reporting Person Rabinowitz Matthew · Officer Title EXECUTIVE CHAIRMAN · Transaction Code S
Traded Sep 14, 2026 · Disclosed Sep 16, 2026
Source: SEC Form 4 · 0001646382-26-000021 · filed 2026-09-16 · View filing →
Sale of 2,246 shares at $333.0656 per share.
Reporting Person Rabinowitz Matthew · Officer Title EXECUTIVE CHAIRMAN · Transaction Code S
Traded Sep 14, 2026 · Disclosed Sep 16, 2026
Source: SEC Form 4 · 0001646382-26-000021 · filed 2026-09-16 · View filing →
Sale of 2,818 shares at $334.2362 per share.
Reporting Person Rabinowitz Matthew · Officer Title EXECUTIVE CHAIRMAN · Transaction Code S
Traded Sep 14, 2026 · Disclosed Sep 16, 2026
Source: SEC Form 4 · 0001646382-26-000021 · filed 2026-09-16 · View filing →
Sale of 3,754 shares at $335.1805 per share.
Reporting Person Rabinowitz Matthew · Officer Title EXECUTIVE CHAIRMAN · Transaction Code S
Traded Sep 14, 2026 · Disclosed Sep 16, 2026
Source: SEC Form 4 · 0001646382-26-000021 · filed 2026-09-16 · View filing →
Sale of 8,459 shares at $336.2660 per share.
Reporting Person Rabinowitz Matthew · Officer Title EXECUTIVE CHAIRMAN · Transaction Code S
Traded Sep 14, 2026 · Disclosed Sep 16, 2026
Source: SEC Form 4 · 0001646382-26-000021 · filed 2026-09-16 · View filing →
Sale of 800 shares at $325.0075 per share.
Reporting Person Rabinowitz Matthew · Officer Title EXECUTIVE CHAIRMAN · Transaction Code S
Traded Sep 11, 2026 · Disclosed Sep 11, 2026
Source: SEC Form 4 · 0001646382-26-000019 · filed 2026-09-11 · View filing →
Sale of 3,647 shares at $326.1077 per share.
Reporting Person Rabinowitz Matthew · Officer Title EXECUTIVE CHAIRMAN · Transaction Code S
Traded Sep 11, 2026 · Disclosed Sep 11, 2026
Source: SEC Form 4 · 0001646382-26-000019 · filed 2026-09-11 · View filing →
Sale of 10,556 shares at $327.1442 per share.
Reporting Person Rabinowitz Matthew · Officer Title EXECUTIVE CHAIRMAN · Transaction Code S
Traded Sep 11, 2026 · Disclosed Sep 11, 2026
Source: SEC Form 4 · 0001646382-26-000019 · filed 2026-09-11 · View filing →
Sale of 17,933 shares at $327.9724 per share.
Reporting Person Rabinowitz Matthew · Officer Title EXECUTIVE CHAIRMAN · Transaction Code S
Traded Sep 11, 2026 · Disclosed Sep 11, 2026
Source: SEC Form 4 · 0001646382-26-000019 · filed 2026-09-11 · View filing →
Sale of 15,764 shares at $328.9502 per share.
Reporting Person Rabinowitz Matthew · Officer Title EXECUTIVE CHAIRMAN · Transaction Code S
Traded Sep 11, 2026 · Disclosed Sep 11, 2026
Source: SEC Form 4 · 0001646382-26-000019 · filed 2026-09-11 · View filing →
Sale of 1,300 shares at $329.6247 per share.
Reporting Person Rabinowitz Matthew · Officer Title EXECUTIVE CHAIRMAN · Transaction Code S
Traded Sep 11, 2026 · Disclosed Sep 11, 2026
Source: SEC Form 4 · 0001646382-26-000019 · filed 2026-09-11 · View filing →
Sale of 15,160 shares at $326.8940 per share.
Reporting Person Moshkevich Solomon · Officer Title PRESIDENT, CLINICALDIAGNOSTICS · Transaction Code S
Traded Sep 2, 2026 · Disclosed Sep 3, 2026
Source: SEC Form 4 · 0002010019-26-000028 · filed 2026-09-03 · View filing →
Sale of 1,698 shares at $320.99 per share.
Reporting Person Chapman Steven Leonard · Officer Title CEO AND PRESIDENT · Transaction Code S
Traded Sep 1, 2026 · Disclosed Sep 3, 2026
Source: SEC Form 4 · 0001711968-26-000022 · filed 2026-09-03 · View filing →
Sale of 1,000 shares at $319.7582 per share.
Reporting Person Moshkevich Solomon · Officer Title PRESIDENT, CLINICALDIAGNOSTICS · Transaction Code S
Traded Sep 1, 2026 · Disclosed Sep 3, 2026
Source: SEC Form 4 · 0002010019-26-000028 · filed 2026-09-03 · View filing →
Sale of 1,400 shares at $320.9225 per share.
Reporting Person Moshkevich Solomon · Officer Title PRESIDENT, CLINICALDIAGNOSTICS · Transaction Code S
Traded Sep 1, 2026 · Disclosed Sep 3, 2026
Source: SEC Form 4 · 0002010019-26-000028 · filed 2026-09-03 · View filing →
Sale of 600 shares at $321.9067 per share.
Reporting Person Moshkevich Solomon · Officer Title PRESIDENT, CLINICALDIAGNOSTICS · Transaction Code S
Traded Sep 1, 2026 · Disclosed Sep 3, 2026
Source: SEC Form 4 · 0002010019-26-000028 · filed 2026-09-03 · View filing →
Sale of 6,517 shares at $321.53 per share.
Reporting Person Fesko John · Officer Title PRESIDENT, CHIEF BUS. OFFICER · Transaction Code S
Traded Aug 10, 2026 · Disclosed Aug 28, 2026FILED +18 DAYS
Source: SEC Form 4 · 0002010135-26-000020 · filed 2026-08-28 · View filing →
Acquisition (code A) of 20,000 shares at $0 per share.
Reporting Person Fesko John · Officer Title PRESIDENT, CHIEF BUS. OFFICER · Transaction Code A
Traded Aug 6, 2026 · Disclosed Aug 28, 2026FILED +22 DAYS
Source: SEC Form 4 · 0002010135-26-000020 · filed 2026-08-28 · View filing →
Sale of 6,000 shares at $325.3237 per share.
Reporting Person Sheena Jonathan · Transaction Code S
Traded Aug 10, 2026 · Disclosed Aug 14, 2026FILED +4 DAYS
Source: SEC Form 4 · 0001646649-26-000030 · filed 2026-08-14 · View filing →